Assessment of Ability Related to Vision

NCT01027312 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2016-11-22

No results posted yet for this study

Summary

To determine the clinical usefulness of a refined third-generation instrument - The Assessment of Ability Related to Vision (AARV) in establishing the amount of disability, charting the detrimental effects of progressive disease and establishing the beneficial effects of treatment

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY
  • Wills Eye

    lead OTHER

Principal Investigators

  • George L Spaeth, MD · Wills Eye Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2010-08-31
Completion
2010-08-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01027312 on ClinicalTrials.gov